Figure 4From: Immune monitoring using the predictive power of immune profilesSurvival of cancer patients categorized by immune profiles. Individual patients with GBM, NHL, or RCC with survival data were assigned a profile from Figure 2. Patients were pooled into profile groups independent of underlying disease. Profiles 1 and 2 were grouped as they represent the only profiles seen in healthy volunteers and compared to the survival of patients with profiles of 3, 4, and 5. P values were calculated by the Mantel-Cox log rank test while adjusting for the contributions of age and disease.Back to article page